| Asthma |
1 |
1 |
| Adherence |
0 |
0.83 |
| Severe Asthma |
0 |
0.49 |
| Inhalers |
0 |
0.46 |
| Child |
0 |
0.27 |
| Steroids |
0 |
0.13 |
| Allergy |
0 |
0.11 |
| Corticosteroids |
0 |
0.11 |
| Immunology |
0 |
0.11 |
| Inhaled Corticosteroid |
0 |
0.11 |
| Revenue and Practice Management |
0 |
0.09 |
| Biologic Therapy |
0 |
0.08 |
| Board Certification |
0 |
0.08 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.08 |
| Colorado |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Hospital |
0 |
0.05 |
| Insurance |
0 |
0.05 |
| Match |
0 |
0.05 |
| Airway Inflammation |
0 |
0.04 |
| Medical Life |
0 |
0.04 |
| Treatment Guidelines |
0 |
0.04 |
| Adolescent Medicine |
0 |
0.03 |
| Airway |
0 |
0.03 |
| Beta-Adrenergic Agonist |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Clinical Guidelines |
0 |
0.03 |
| Data Collection |
0 |
0.03 |
| Dorsum |
0 |
0.03 |
| Eosinophils |
0 |
0.03 |
| Fellowship |
0 |
0.03 |
| Financial Reimbursement |
0 |
0.03 |
| Heart |
0 |
0.03 |
| Interprofessional Continuing Education |
0 |
0.03 |
| Lung |
0 |
0.03 |
| Medicaid |
0 |
0.03 |
| Nitric Oxide |
0 |
0.03 |
| Pulmonary Function Test |
0 |
0.03 |
| Severity Index |
0 |
0.03 |
| UK Site Content |
0 |
0.03 |
| Young Adult |
0 |
0.03 |